Karagiannakis DS, Markakis G, Lakiotaki D, Cholongitas E, Vlachogiannakos J, Papatheodoridis G. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease. European journal of gastroenterology & hepatology. 2022;34:961–966.

Rousssos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Hounta A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. High levels of all-cause mortality among people who inject drugs in Greece in 2018–2022. medRxiv. 2022:2022–10.

Papatheodoridis GV, Mimidis K, Manolakopoulos S, Triantos CU, Vlachogiannakos I, Veretanos C, Deutsch M, Karatapanis S, Goulis I, Elefsiniotis IS, et al. FACTORS OF UNDERDIAGNOSIS AND PREVALENCE OF HEPATITIS D VIRUS (HDV) INFECTION IN HBsAg-POSITIVE PATIENTS: A HELLENIC MULTICENTER REAL-LIFE CLINICAL STUDY (HERACLIS-HDV). In: HEPATOLOGY. Vol. 76. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2022. pp. S293–S294.

Cholongitas E, Tsilingiris D, Diamantopoulou P, Mastrogianni E, Tentolouris A, Karagiannakis D, Moyssakis I, Papatheodoridis GV, Tentolouris NIKOLAOS. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. Hormones. 2022:1–13.

Karagiannakis D, Markakis G, Lakiotaki D, Michailidou E, Fytili P, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. Correlations of 2D-Shear wave and transient elastography liver stiffness measurements in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2022;77:S429.